Moderna shares are trading lower after RBC Capital downgraded the stock from Outperform to Sector Perform and lowered its price target from $125 to $90.
Portfolio Pulse from Benzinga Newsdesk
Moderna shares are trading lower after RBC Capital downgraded the stock from Outperform to Sector Perform and lowered its price target from $125 to $90.
August 05, 2024 | 6:28 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
RBC Capital downgraded Moderna from Outperform to Sector Perform and reduced its price target from $125 to $90, causing the stock to trade lower.
The downgrade from RBC Capital and the significant reduction in the price target are likely to negatively impact investor sentiment and lead to a short-term decline in Moderna's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100